{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:17:22Z","timestamp":1787725042072,"version":"build-2784847793"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Youth Talent Science and Technology Project of Health Commission of Changzhou","award":["QN202223"],"award-info":[{"award-number":["QN202223"]}]},{"name":"Education Research Project of Nanjing Medical University","award":["2023ZC086"],"award-info":[{"award-number":["2023ZC086"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11596-025-00130-3","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T11:12:49Z","timestamp":1764155569000},"page":"1479-1490","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["LncRNA C9orf139 Promotes Acute Myeloid Leukemia Cell Proliferation by Sponging miR-24-3p to Upregulate TAOK1"],"prefix":"10.1007","volume":"45","author":[{"given":"Wei","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-hui","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-zhang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"issue":"4","key":"130_CR1","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1182\/bloodadvances.2021005585","volume":"6","author":"A Bataller","year":"2022","unstructured":"Bataller A, Garrido A, Guijarro F, et al. European Leukemia Net 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol. Blood Adv. 2022;6(4):1193\u20131206.","journal-title":"Blood Adv."},{"key":"130_CR2","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3389\/fphar.2020.01321","volume":"11","author":"Z Yu","year":"2020","unstructured":"Yu Z, Li L, Wang C, et al. Cantharidin Induces Apoptosis and Promotes Differentiation of AML Cells Through Nuclear Receptor Nur77-Mediated Signaling Pathway. Front Pharmacol. 2020;11:1321.","journal-title":"Front Pharmacol."},{"issue":"8","key":"130_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41408-022-00712-7","volume":"12","author":"F Vergez","year":"2022","unstructured":"Vergez F, Largeaud L, Bertoli S, et al. Phenotypically-defined stages of leukemia arrest predict main driver mutations subgroups, and outcome in acute myeloid leukemia. Blood Cancer J. 2022;12(8):117.","journal-title":"Blood Cancer J."},{"issue":"1","key":"130_CR4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12935-021-01746-w","volume":"21","author":"M Levin","year":"2021","unstructured":"Levin M, Stark M, Ofran Y, et al. Deciphering molecular mechanisms underlying chemoresistance in relapsed AML patients: towards precision medicine overcoming drug resistance. Cancer Cell Int. 2021;21(1):53.","journal-title":"Cancer Cell Int."},{"key":"130_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.623952","volume":"11","author":"C R\u00e9cher","year":"2021","unstructured":"R\u00e9cher C. Clinical Implications of Inflammation in Acute Myeloid Leukemia. Front Oncol. 2021;11:623952.","journal-title":"Front Oncol."},{"key":"130_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.829137","volume":"11","author":"X Han","year":"2022","unstructured":"Han X, Zhang S. Role of Long Non-Coding RNA LINC00641 in Cancer. Front Oncol. 2022;11:829137.","journal-title":"Front Oncol."},{"issue":"11","key":"130_CR7","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.3390\/cancers11111638","volume":"11","author":"M Gourvest","year":"2019","unstructured":"Gourvest M, Brousset P, Bousquet M. Long Non-coding RNAs in Acute Myeloid Leukemia: Functional Characterization and Clinical Relevance. Cancers (Basel). 2019;11(11):1638.","journal-title":"Cancers (Basel)."},{"key":"130_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.554759","volume":"10","author":"X Wu","year":"2020","unstructured":"Wu X, Sui Z, Zhang H, et al. Integrated Analysis of lncRNA-Mediated ceRNA Network in Lung Adenocarcinoma. Front Oncol. 2020;10:554759.","journal-title":"Front Oncol."},{"issue":"1","key":"130_CR9","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41420-022-01061-x","volume":"8","author":"J Xu","year":"2022","unstructured":"Xu J, Xu J, Liu X, et al. The role of lncRNA-mediated ceRNA regulatory networks in pancreatic cancer. Cell Death Discov. 2022;8(1):287.","journal-title":"Cell Death Discov."},{"issue":"7","key":"130_CR10","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/cbf.3521","volume":"38","author":"X Dong","year":"2020","unstructured":"Dong X, Xu X, Guan Y. LncRNA LINC00899 promotes progression of acute myeloid leukaemia by modulating miR-744-3p\/YY1 signalling. Cell Biochem Funct. 2020;38(7):955\u2013964.","journal-title":"Cell Biochem Funct."},{"issue":"4","key":"130_CR11","first-page":"2311","volume":"41","author":"Y Yang","year":"2019","unstructured":"Yang Y, Dai W, Sun Y, et al. Long non-coding RNA linc00239 promotes malignant behaviors and chemoresistance against doxorubicin partially via activation of the PI3K\/Akt\/mTOR pathway in acute myeloid leukaemia cells. Oncol Rep. 2019;41(4):2311\u20132320.","journal-title":"Oncol Rep."},{"issue":"4","key":"130_CR12","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/1878-0261.12661","volume":"15","author":"H Zhang","year":"2021","unstructured":"Zhang H, Liu L, Chen L, et al. Long non-coding RNA DANCR confers cytarabine resistance in acute myeloid leukemia by activating autophagy via the miR-874-3P\/ATG16L1 axis. Mol Oncol. 2021;15(4):1203\u20131216.","journal-title":"Mol Oncol."},{"issue":"11","key":"130_CR13","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.4251\/wjgo.v12.i11.1272","volume":"12","author":"JN Ge","year":"2020","unstructured":"Ge JN, Yan D, Ge CL, et al. LncRNA C9orf139 can regulate the growth of pancreatic cancer by mediating the miR-663a\/Sox12 axis. World J Gastrointest Oncol. 2020;12(11):1272\u20131287.","journal-title":"World J Gastrointest Oncol."},{"key":"130_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2022.101487","volume":"24","author":"X Yang","year":"2022","unstructured":"Yang X, Shen Z, Tian M, et al. LncRNA C9orf139 can regulate the progression of esophageal squamous carcinoma by mediating the miR-661\/HDAC11 axis. Transl Oncol. 2022;24:101487.","journal-title":"Transl Oncol."},{"issue":"6","key":"130_CR15","doi-asserted-by":"publisher","first-page":"4559","DOI":"10.1002\/jcb.26598","volume":"119","author":"J Song","year":"2018","unstructured":"Song J, Xu Q, Zhang H, et al. Five key lncRNAs considered as prognostic targets for predicting pancreatic ductal adenocarcinoma. J Cell Biochem. 2018;119(6):4559\u20134569.","journal-title":"J Cell Biochem."},{"key":"130_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.976850","volume":"13","author":"S Jiang","year":"2022","unstructured":"Jiang S, Li Z, Dou R, et al. Construction and validation of a novel cuproptosis-related long non-coding RNA signature for predicting the outcome of prostate cancer. Front Genet. 2022;13:976850.","journal-title":"Front Genet."},{"key":"130_CR17","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fendo.2018.00402","volume":"9","author":"J O\u2019Brien","year":"2018","unstructured":"O\u2019Brien J, Hayder H, Zayed Y, et al. Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation. Front Endocrinol (Lausanne). 2018;9:402.","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"4","key":"130_CR18","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1182\/blood-2010-09-191312","volume":"117","author":"G Marcucci","year":"2011","unstructured":"Marcucci G, Mr\u00f3zek K, Radmacher MD, et al. The prognostic and functional role of microRNAs in acute myeloid leukemia. Blood. 2011;117(4):1121\u20131129.","journal-title":"Blood."},{"issue":"1","key":"130_CR19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41392-020-0206-y","volume":"5","author":"Z Gao","year":"2020","unstructured":"Gao Z, Zhou L, Hua S, et al. miR-24-3p promotes colon cancer progression by targeting ING1. Signal Transduct Target Ther. 2020;5(1):171.","journal-title":"Signal Transduct Target Ther."},{"issue":"5","key":"130_CR20","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.1002\/jcb.26553","volume":"119","author":"L Yan","year":"2018","unstructured":"Yan L, Ma J, Zhu Y, et al. miR-24-3p promotes cell migration and proliferation in lung cancer by targeting SOX7. J Cell Biochem. 2018;119(5):3989\u20133998.","journal-title":"J Cell Biochem."},{"key":"130_CR21","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.3389\/fonc.2019.01499","volume":"9","author":"W Huang","year":"2020","unstructured":"Huang W, Gu J, Tao T, et al. MiR-24-3p Inhibits the Progression of Pancreatic Ductal Adenocarcinoma Through LAMB3 Downregulation. Front Oncol. 2020;9:1499.","journal-title":"Front Oncol."},{"key":"130_CR22","doi-asserted-by":"crossref","unstructured":"Otmani K, Rouas R, Lagneaux L, et al. Acute myeloid leukemia-derived exosomes deliver miR-24-3p to hinder the T-cell immune response through DENN\/MADD targeting in the NF-\u03baB signaling pathways. Cell Commun Signal. 2023;21(1):253.","DOI":"10.1186\/s12964-023-01259-1"},{"issue":"6","key":"130_CR23","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.ajpath.2017.02.016","volume":"187","author":"Y Yuan","year":"2017","unstructured":"Yuan Y, Kluiver J, Koerts J, et al. miR-24-3p Is Overexpressed in Hodgkin Lymphoma and Protects Hodgkin and Reed-Sternberg Cells from Apoptosis. Am J Pathol. 2017;187(6):1343\u20131355.","journal-title":"Am J Pathol."},{"issue":"20","key":"130_CR24","doi-asserted-by":"publisher","first-page":"7463","DOI":"10.3390\/ijms21207463","volume":"21","author":"CY Fang","year":"2020","unstructured":"Fang CY, Lai TC, Hsiao M, et al. The Diverse Roles of TAO Kinases in Health and Diseases. Int J Mol Sci. 2020;21(20):7463.","journal-title":"Int J Mol Sci."},{"key":"130_CR25","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3389\/fcell.2020.00142","volume":"8","author":"Y Feng","year":"2020","unstructured":"Feng Y, Hu S, Li L, et al. LncRNA NR-104098 Inhibits AML Proliferation and Induces Differentiation Through Repressing EZH2 Transcription by Interacting With E2F1. Front Cell Dev Biol. 2020;8:142.","journal-title":"Front Cell Dev Biol."},{"issue":"1","key":"130_CR26","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1038\/s41598-022-05797-5","volume":"12","author":"F Zhong","year":"2022","unstructured":"Zhong F, Yao F, Cheng Y, et al. m6A-related lncRNAs predict prognosis and indicate immune microenvironment in acute myeloid leukemia. Sci Rep. 2022;12(1):1759.","journal-title":"Sci Rep."},{"issue":"11","key":"130_CR27","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.3390\/biom11111665","volume":"11","author":"S Ghafouri-Fard","year":"2021","unstructured":"Ghafouri-Fard S, Fathi M, Zhai T, et al. LncRNAs: Novel Biomarkers for Pancreatic Cancer. Biomolecules. 2021;11(11):1665.","journal-title":"Biomolecules."},{"issue":"11","key":"130_CR28","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1101\/gr.220707.117","volume":"27","author":"J Kuipers","year":"2017","unstructured":"Kuipers J, Jahn K, Raphael BJ, et al. Single-cell sequencing data reveal widespread recurrence and loss of mutational hits in the life histories of tumors. Genome Res. 2017;27(11):1885\u20131894.","journal-title":"Genome Res."},{"issue":"1","key":"130_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13148-018-0587-8","volume":"11","author":"W Si","year":"2019","unstructured":"Si W, Shen J, Zheng H, et al. The role and mechanisms of action of microRNAs in cancer drug resistance. Clin Epigenetics. 2019;11(1):25.","journal-title":"Clin Epigenetics."},{"key":"130_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111528","volume":"138","author":"BM Hussen","year":"2021","unstructured":"Hussen BM, Hidayat HJ, Salihi A, et al. MicroRNA: A signature for cancer progression. Biomed Pharmacother. 2021;138:111528.","journal-title":"Biomed Pharmacother."},{"issue":"2","key":"130_CR31","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3892\/or.2016.5326","volume":"37","author":"G Yu","year":"2017","unstructured":"Yu G, Jia Z, Dou Z. miR-24-3p regulates bladder cancer cell proliferation, migration, invasion and autophagy by targeting DEDD. Oncol Rep. 2017;37(2):1123\u20131131.","journal-title":"Oncol Rep."},{"issue":"16","key":"130_CR32","doi-asserted-by":"publisher","first-page":"12868","DOI":"10.18632\/oncotarget.24403","volume":"9","author":"A Khodadadi-Jamayran","year":"2018","unstructured":"Khodadadi-Jamayran A, Akgol-Oksuz B, Afanasyeva Y, et al. Prognostic role of elevated mir-24-3p in breast cancer and its association with the metastatic process. Oncotarget. 2018;9(16):12868\u201312878.","journal-title":"Oncotarget."},{"key":"130_CR33","doi-asserted-by":"crossref","unstructured":"Wang H, Chen C, Ding K, et al. MiR-24-3p as a prognostic indicator for multiple cancers: from a meta-analysis view. Biosci Rep. 2020;40 (12):BSR20202938","DOI":"10.1042\/BSR20202938"},{"issue":"1","key":"130_CR34","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ajhg.2019.05.005","volume":"105","author":"M Dulovic-Mahlow","year":"2019","unstructured":"Dulovic-Mahlow M, Trinh J, Kandaswamy KK, et al. De Novo Variants in TAOK1 Cause Neurodevelopmental Disorders. Am J Hum Genet. 2019;105(1):213\u2013220.","journal-title":"Am J Hum Genet."}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-025-00130-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-025-00130-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-025-00130-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T09:15:57Z","timestamp":1766999757000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-025-00130-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["130"],"URL":"https:\/\/doi.org\/10.1007\/s11596-025-00130-3","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"17 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This study was approved by the Ethical Committee of Changzhou Second People\u2019s Hospital (Ethics number [2023] KY311-01) and strictly adhered to the ethical principles of the Declaration of Helsinki. As this study was a retrospective analysis, did not involve direct intervention with patients, and all data were anonymized, the Ethics Committee approved the waiver of informed consent. Animal ethics license: SYXK (Su) 2020\u20130022.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publication"}}]}}